Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
102
2.970
Why?
Ophthalmologic Surgical Procedures
5
2017
56
2.180
Why?
Angiogenesis Inhibitors
11
2022
216
2.000
Why?
Retina
11
2016
280
1.720
Why?
Glaucoma
4
2017
216
1.610
Why?
Eye Foreign Bodies
5
2016
23
1.590
Why?
Alloys
4
2013
34
1.580
Why?
Macular Edema
4
2022
41
1.540
Why?
Retinal Detachment
6
2019
56
1.520
Why?
Vitrectomy
7
2019
62
1.470
Why?
Diabetic Retinopathy
6
2019
171
1.440
Why?
Glaucoma Drainage Implants
3
2016
46
1.400
Why?
Retinal Diseases
5
2017
86
1.240
Why?
Intraocular Pressure
7
2017
296
1.220
Why?
Nanopores
2
2020
7
1.200
Why?
Intravitreal Injections
7
2022
54
1.170
Why?
Membranes, Artificial
2
2020
68
1.160
Why?
Nanotechnology
2
2020
119
1.100
Why?
Suction
3
2015
32
1.010
Why?
Sutures
3
2015
53
0.960
Why?
Choroidal Neovascularization
4
2011
51
0.950
Why?
Anterior Eye Segment
2
2017
9
0.950
Why?
Swine
10
2017
743
0.930
Why?
Suture Techniques
3
2015
121
0.930
Why?
Equipment Design
6
2017
518
0.900
Why?
Lens Implantation, Intraocular
2
2015
59
0.870
Why?
Retinitis
1
2022
19
0.800
Why?
Retinal Vasculitis
1
2022
10
0.800
Why?
Aneurysm
1
2022
30
0.790
Why?
Vitreoretinopathy, Proliferative
2
2019
12
0.730
Why?
Antibodies, Monoclonal
6
2020
1355
0.730
Why?
Vascular Endothelial Growth Factor A
6
2020
501
0.730
Why?
Immunosuppressive Agents
3
2013
686
0.700
Why?
Retinal Vessels
2
2015
63
0.690
Why?
Durapatite
1
2020
35
0.690
Why?
Cytomegalovirus Retinitis
2
2013
18
0.680
Why?
Complement System Proteins
2
2020
306
0.670
Why?
Isoxazoles
2
2013
54
0.670
Why?
Eye Injuries, Penetrating
3
2016
16
0.670
Why?
Scleral Buckling
3
2012
18
0.670
Why?
Endophthalmitis
2
2017
28
0.660
Why?
Disease Models, Animal
8
2020
3943
0.660
Why?
Stents
2
2013
504
0.610
Why?
Fluorocarbons
2
2012
109
0.580
Why?
Anterior Chamber
1
2017
20
0.560
Why?
Glucocorticoids
2
2020
575
0.550
Why?
Transducers
1
2017
27
0.550
Why?
Strabismus
1
2017
28
0.550
Why?
Sclera
2
2015
36
0.530
Why?
Filtering Surgery
1
2016
22
0.530
Why?
Trabeculectomy
1
2017
71
0.520
Why?
Surgical Instruments
2
2013
52
0.520
Why?
Fovea Centralis
2
2006
10
0.510
Why?
Retinal Perforations
2
2005
14
0.500
Why?
Ocular Hypertension
1
2016
64
0.500
Why?
Drug Resistance, Multiple, Viral
2
2013
11
0.500
Why?
Ophthalmology
2
2013
81
0.490
Why?
Lenses, Intraocular
1
2015
43
0.480
Why?
Laser Therapy
1
2017
130
0.480
Why?
Monitoring, Physiologic
1
2017
267
0.480
Why?
Lasers
1
2015
132
0.470
Why?
Device Removal
1
2016
137
0.460
Why?
Prostheses and Implants
1
2016
135
0.460
Why?
Tomography, Optical Coherence
7
2015
182
0.460
Why?
Ischemia
2
2017
395
0.450
Why?
Antiviral Agents
2
2013
704
0.450
Why?
Fluorescein Angiography
9
2012
141
0.440
Why?
Rabbits
3
2020
761
0.430
Why?
Models, Cardiovascular
1
2015
190
0.430
Why?
Retinal Degeneration
2
2015
37
0.420
Why?
Animals
18
2020
34501
0.420
Why?
Artificial Lens Implant Migration
1
2013
3
0.420
Why?
Choroid
3
2015
61
0.420
Why?
Macular Degeneration
6
2015
157
0.420
Why?
Viscosupplements
1
2012
10
0.410
Why?
Gravitation
1
2012
16
0.410
Why?
Silicone Oils
1
2012
26
0.410
Why?
Silicon
1
2012
14
0.410
Why?
Pupil Disorders
1
2012
5
0.400
Why?
Eye Enucleation
1
2012
11
0.400
Why?
Iris
1
2012
19
0.400
Why?
Viremia
1
2013
130
0.400
Why?
Quantum Dots
1
2012
36
0.400
Why?
Silicone Elastomers
1
2012
8
0.390
Why?
Prosthesis Implantation
1
2013
143
0.390
Why?
Uveitis, Posterior
1
2012
12
0.390
Why?
Surgical Stapling
1
2012
13
0.390
Why?
Electric Stimulation Therapy
1
2012
60
0.380
Why?
Fluocinolone Acetonide
1
2012
19
0.380
Why?
Vitreous Hemorrhage
2
2015
5
0.380
Why?
Cataract Extraction
1
2013
96
0.370
Why?
Models, Biological
4
2015
1693
0.370
Why?
Vascular Endothelial Growth Factors
1
2011
65
0.370
Why?
Materials Testing
1
2012
346
0.340
Why?
Cytomegalovirus
2
2013
153
0.340
Why?
Oxygen
1
2015
901
0.340
Why?
Humans
47
2022
128524
0.330
Why?
Anti-Inflammatory Agents
1
2012
469
0.300
Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
250
0.290
Why?
Biocompatible Materials
1
2012
395
0.290
Why?
Electroretinography
5
2016
45
0.280
Why?
von Hippel-Lindau Disease
1
2007
11
0.280
Why?
Injections
5
2012
170
0.270
Why?
Pigment Epithelium of Eye
2
2006
34
0.270
Why?
Puerperal Disorders
1
2007
30
0.270
Why?
Recombinant Fusion Proteins
4
2022
632
0.270
Why?
Drug Implants
2
2020
82
0.260
Why?
Uveal Diseases
1
2006
5
0.260
Why?
Ocular Hypotension
1
2006
10
0.260
Why?
Fusobacterium Infections
1
2006
6
0.260
Why?
Antibodies, Monoclonal, Humanized
6
2015
759
0.260
Why?
Pharyngeal Diseases
1
2006
14
0.260
Why?
Needles
2
2017
57
0.260
Why?
Epiretinal Membrane
1
2005
7
0.260
Why?
Ciliary Body
1
2006
33
0.260
Why?
Telangiectasis
1
2005
6
0.250
Why?
Visual Acuity
7
2019
320
0.250
Why?
Rats, Inbred BN
3
2011
53
0.250
Why?
Dementia
2
2022
227
0.240
Why?
Uveitis
1
2006
127
0.240
Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
89
0.240
Why?
Female
26
2022
68127
0.240
Why?
Kidney Transplantation
2
2013
604
0.230
Why?
Injections, Intraocular
2
2015
10
0.230
Why?
Polypropylenes
2
2015
13
0.230
Why?
Middle Aged
17
2019
30893
0.210
Why?
Laser Coagulation
3
2012
57
0.200
Why?
Autoimmune Diseases
1
2006
423
0.200
Why?
Optic Atrophy
1
2022
10
0.200
Why?
Hearing Loss, Central
1
2022
5
0.200
Why?
Bevacizumab
6
2015
131
0.200
Why?
Rats
4
2012
5168
0.190
Why?
Retinal Vein Occlusion
2
2015
13
0.190
Why?
Cell Count
2
2012
314
0.190
Why?
Dialysis
1
2020
18
0.180
Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.170
Why?
Orbital Neoplasms
1
2000
20
0.170
Why?
Time Factors
4
2017
6503
0.170
Why?
Adsorption
1
2020
138
0.170
Why?
Follow-Up Studies
5
2015
4898
0.160
Why?
Male
21
2019
62883
0.160
Why?
Adult
11
2022
35315
0.160
Why?
Biomarkers
2
2020
3881
0.150
Why?
Wet Macular Degeneration
1
2019
46
0.150
Why?
Fluorescein-5-isothiocyanate
2
2009
36
0.150
Why?
Eye Diseases, Hereditary
1
2018
11
0.150
Why?
Geographic Atrophy
1
2019
69
0.150
Why?
Miniaturization
2
2015
24
0.150
Why?
Dextrans
2
2009
82
0.150
Why?
Iris Diseases
1
2017
6
0.140
Why?
Choroid Diseases
1
2017
10
0.140
Why?
Glomerulonephritis, Membranoproliferative
1
1997
13
0.140
Why?
Enzyme-Linked Immunosorbent Assay
1
2019
814
0.140
Why?
Dark Adaptation
2
2012
14
0.140
Why?
Hypertension
1
2006
1238
0.140
Why?
Antimony
1
2016
5
0.140
Why?
Infliximab
2
2007
100
0.130
Why?
Dose-Response Relationship, Drug
3
2014
1943
0.130
Why?
Aged, 80 and over
6
2019
7040
0.130
Why?
Polymers
1
2020
471
0.130
Why?
Pressure
1
2017
239
0.130
Why?
Sclerostomy
1
2015
4
0.130
Why?
Foreign-Body Migration
1
2016
34
0.120
Why?
Treatment Outcome
9
2016
10163
0.120
Why?
Gyrate Atrophy
1
2015
2
0.120
Why?
Aged
10
2020
21971
0.120
Why?
Vitreoretinal Surgery
1
2015
3
0.120
Why?
Eye Infections, Bacterial
1
2015
26
0.120
Why?
Vitreous Detachment
1
2015
7
0.120
Why?
Stress, Mechanical
1
2017
465
0.120
Why?
Diagnostic Techniques, Ophthalmological
1
2015
38
0.120
Why?
Equipment Failure Analysis
1
2015
131
0.120
Why?
Partial Pressure
1
2015
29
0.120
Why?
Health Knowledge, Attitudes, Practice
2
2014
1271
0.120
Why?
Hemoglobin SC Disease
1
2015
13
0.120
Why?
Prosthesis Failure
1
2016
118
0.120
Why?
Biopsy, Needle
1
2015
189
0.120
Why?
Feedback
1
2015
159
0.120
Why?
Oculomotor Muscles
1
2014
38
0.120
Why?
International Normalized Ratio
1
2014
47
0.120
Why?
Protein Binding
1
2020
2097
0.110
Why?
Postoperative Care
1
2015
243
0.110
Why?
Exchange Transfusion, Whole Blood
1
2013
14
0.110
Why?
Down Syndrome
1
2000
470
0.110
Why?
Retinal Artery Occlusion
1
2013
8
0.110
Why?
In Vitro Techniques
1
2015
1043
0.110
Why?
Tendons
1
2014
127
0.110
Why?
Warfarin
1
2014
147
0.110
Why?
Metabolomics
1
2018
597
0.100
Why?
Specific Gravity
1
2012
10
0.100
Why?
Transducers, Pressure
1
2012
13
0.100
Why?
Diabetes Mellitus, Type 2
2
2012
2430
0.100
Why?
Erythrocyte Transfusion
1
2015
182
0.100
Why?
Adaptation, Ocular
1
2012
4
0.100
Why?
Research Design
1
2019
1038
0.100
Why?
Minerals
1
2012
39
0.100
Why?
Rats, Mutant Strains
1
2012
24
0.100
Why?
Pupil
1
2012
13
0.100
Why?
Viscosity
1
2012
89
0.100
Why?
Antineoplastic Agents
2
2020
2058
0.100
Why?
Acetates
1
2012
97
0.100
Why?
Corneal Endothelial Cell Loss
1
2012
2
0.100
Why?
Retinal Neovascularization
1
2012
22
0.100
Why?
Sodium Chloride
1
2012
138
0.100
Why?
Endothelium, Corneal
1
2012
16
0.100
Why?
Swine, Miniature
1
2012
78
0.100
Why?
Tumor Necrosis Factor-alpha
2
2007
1190
0.100
Why?
Electrodes, Implanted
1
2012
106
0.100
Why?
Microsurgery
1
2012
69
0.090
Why?
Retinal Ganglion Cells
1
2012
97
0.090
Why?
Drug Combinations
1
2012
323
0.090
Why?
Adolescent
4
2019
20213
0.090
Why?
Bruch Membrane
1
2011
6
0.090
Why?
Gold
1
2012
117
0.090
Why?
Polyglycolic Acid
1
2011
42
0.090
Why?
Registries
1
2019
1878
0.090
Why?
Administration, Oral
1
2013
757
0.090
Why?
Drug Compounding
1
2011
95
0.090
Why?
Dissection
1
2011
56
0.090
Why?
Computer Simulation
1
2015
939
0.090
Why?
Delayed-Action Preparations
1
2011
176
0.090
Why?
Models, Animal
1
2012
367
0.080
Why?
Atrial Fibrillation
1
2014
378
0.080
Why?
Anemia, Sickle Cell
1
2013
252
0.080
Why?
Retrospective Studies
8
2015
14460
0.080
Why?
Lactic Acid
1
2011
295
0.080
Why?
Cell Survival
1
2012
1077
0.080
Why?
Bacteria
1
2015
811
0.080
Why?
Scotoma
1
2008
5
0.080
Why?
Proliferating Cell Nuclear Antigen
1
2007
50
0.070
Why?
Optic Neuropathy, Ischemic
1
2007
30
0.070
Why?
Papilledema
1
2007
39
0.070
Why?
Severity of Illness Index
2
2014
2736
0.070
Why?
Pilot Projects
1
2012
1558
0.070
Why?
Visual Fields
3
2007
88
0.070
Why?
RNA, Catalytic
1
2007
185
0.070
Why?
Retinitis Pigmentosa
1
2006
20
0.070
Why?
Glycogen Storage Disease Type IIb
1
2006
25
0.070
Why?
Triamcinolone Acetonide
1
2006
27
0.070
Why?
Fusobacterium necrophorum
1
2006
1
0.070
Why?
Polyethylene Glycols
1
2011
597
0.060
Why?
Indocyanine Green
1
2005
19
0.060
Why?
Vision, Low
3
2013
16
0.060
Why?
Myopia
1
2006
47
0.060
Why?
Coloring Agents
1
2005
76
0.060
Why?
Eye Injuries
1
2006
45
0.060
Why?
Infusions, Intravenous
1
2006
384
0.060
Why?
Young Adult
2
2019
12320
0.060
Why?
Staining and Labeling
1
2005
139
0.060
Why?
Syndrome
1
2006
335
0.060
Why?
Cataract
1
2006
194
0.050
Why?
Multivariate Analysis
2
2019
1494
0.050
Why?
Diagnosis, Differential
1
2007
1416
0.050
Why?
Ranibizumab
2
2013
20
0.050
Why?
Blindness
2
2013
37
0.050
Why?
Keratitis
1
2000
11
0.040
Why?
Postoperative Complications
1
2012
2479
0.040
Why?
Exophthalmos
1
2000
17
0.040
Why?
Chronic Disease
1
2006
1701
0.040
Why?
Immunophenotyping
1
2000
312
0.040
Why?
Xanthine
1
2018
7
0.040
Why?
Tomography, X-Ray Computed
2
2016
2521
0.040
Why?
Combined Modality Therapy
2
2013
1209
0.040
Why?
Electrooculography
1
1997
12
0.040
Why?
Visual Field Tests
1
1997
16
0.040
Why?
Color Vision Defects
1
1997
7
0.040
Why?
Fundus Oculi
1
1997
61
0.030
Why?
Purines
1
2018
169
0.030
Why?
Cohort Studies
2
2019
5369
0.030
Why?
Odds Ratio
1
2019
1022
0.030
Why?
Photic Stimulation
1
1997
240
0.030
Why?
Child
2
2015
20721
0.030
Why?
Vision Disorders
1
1997
135
0.030
Why?
Microbiological Techniques
1
2015
30
0.030
Why?
Colony Count, Microbial
1
2015
116
0.030
Why?
Endotamponade
1
2015
2
0.030
Why?
Myopia, Degenerative
1
2015
4
0.030
Why?
Metabolome
1
2018
318
0.030
Why?
Tenon Capsule
1
2014
3
0.030
Why?
Tissue Adhesions
1
2015
29
0.030
Why?
Mass Spectrometry
1
2018
660
0.030
Why?
Photography
1
2015
98
0.030
Why?
Atrophy
1
2015
172
0.030
Why?
Conjunctiva
1
2014
51
0.030
Why?
Biometry
1
2014
69
0.030
Why?
Disease Progression
2
2015
2603
0.030
Why?
Pregnancy
1
2007
6297
0.030
Why?
Glucose
1
2018
983
0.030
Why?
Risk Factors
2
2019
9727
0.030
Why?
Fatty Acids, Omega-3
1
2014
137
0.030
Why?
Retreatment
1
2012
70
0.020
Why?
Risk Assessment
2
2014
3256
0.020
Why?
Kaplan-Meier Estimate
1
2014
857
0.020
Why?
Oxidative Stress
1
2018
1188
0.020
Why?
Global Health
1
2014
326
0.020
Why?
Survival Analysis
1
2014
1265
0.020
Why?
Proportional Hazards Models
1
2014
1208
0.020
Why?
Health Care Costs
1
2014
395
0.020
Why?
Phenotype
1
2019
3050
0.020
Why?
Antioxidants
1
2014
543
0.020
Why?
Anticoagulants
1
2014
613
0.020
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
411
0.020
Why?
Clinical Trials, Phase II as Topic
1
2009
71
0.020
Why?
Clinical Trials, Phase I as Topic
1
2009
49
0.020
Why?
Comorbidity
1
2014
1540
0.020
Why?
Colorado
1
2019
4392
0.020
Why?
Prospective Studies
2
2012
7043
0.020
Why?
Retinal Artery
1
2007
16
0.020
Why?
Cerebral Angiography
1
2007
107
0.020
Why?
Lysosomal-Associated Membrane Protein 2
1
2006
28
0.020
Why?
Infant
1
2000
8913
0.020
Why?
Frameshift Mutation
1
2006
31
0.020
Why?
Secondary Prevention
1
2007
220
0.020
Why?
Prognosis
1
2014
3780
0.020
Why?
Anti-Bacterial Agents
1
2015
1667
0.020
Why?
Adrenal Cortex Hormones
1
2008
518
0.010
Why?
Double-Blind Method
1
2007
1860
0.010
Why?
RNA, Messenger
1
2007
2674
0.010
Why?
Aging
1
2008
1770
0.010
Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)